HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 21, No 08, August 2017 – Eye – the Window to your Soul       » Palm-Sized PCR Device for Rapid Real-Time Detection of Viruses       » Scientists Uncover New Mechanism for Diabetic Neuropathy       » China Enlists AI to Diagnose Breast Cancer       » Philips and Singapore Institute of Advanced Medicine Holdings Sign Agreement to Open First-of-its-kind Oncology Center in Singapore       » Guardian Partners with MyDoc to Address Singapore's Population Health Needs through Integrating Technology and Self-Care       » Database Boosts Shanghai's Technology Aim      
INSIDE INDUSTRY
Avian Influenza A (H7N9) threatens, GenScript supports researchers in impending battle

The World Health Organization reported three cases in which humans were infected with Avian Influenza A (H7N9) Virus in China. These were the first reports of the H7N9 strain infecting humans. Currently, it is unclear whether or not the virus can be spread via human-to-human contact, however genetic sequences for the virus have been published, and the Center for Disease Control has reported the start of vaccine development for the virus.

The foundation of vaccine development is often the identification and re-construction of the parts of the viral genome sequence that encode for antigens capable of eliciting the necessary immune response to fight the live virus. Gene synthesis is a powerful tool for vaccine development, enabling the rapid construction of any vector expressing an antigen capable of eliciting the necessary immune response.

GenScript is committed to arming researchers with the necessary custom bioreagents, such as synthetic DNA, to accelerate research to prevent the spread of disease. As proof of this commitment, GenScript recently became the fastest global biotech company to complete synthesis of a key H7N9-related gene, in only four days, using the Rush Gene Synthesis Service . In an effort to accelerate critical research, GenScript has synthesized over 30 crucial H7N9-related genes in our collaborations with prestigious institutions including the NIH, CDC, and Chinese Academy of Science, as well as leading vaccine centers in the United States and research organizations in Hong Kong and Japan.

Whether or not an H7N9 outbreak will occur remains to be seen, but at GenScript, we know that the best way to prevent the spread of disease is to be prepared.

Click here for the complete issue.

NEWS CRUNCH  
news Vitafoods Asia 2017: Industry players optimistic of future
news Nestlé Introduces their Singapore R&D Centre
news Vitafoods Asia Elevates 2017 Learning Programme
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2017
January:
Healthcare Focus: LUNGS
February:
War on CANCER
March:
Get to Know TCM
April:
Diabetes: The Big Picture
May:
The Piece of Your Mind - Brain Health/Science
June:
Advocacies in Support of Rare Disease Patients
July:
Food Science & Technology
August:
Eye – the Window to your Soul
September:
Emerging Infectious Diseases
October:
No. 1 Killer — Heart Diseases
November:
Diseases threatening our Children
December:
Skin Diseases/Allergic Reactions
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2017 World Scientific Publishing Co Pte Ltd  •  Privacy Policy